PHR Phreesia, Inc.

NYSE phreesia.com


$ 22.23 $ -0.46 (-2.02 %)    

Friday, 17-Oct-2025 18:02:38 EDT
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 22.29
$ 22.50
$ 22.00 x 12
$ 23.20 x 2,548
$ 22.14 - $ 22.65
$ 17.07 - $ 32.76
361,906
na
1.34B
$ 1.54
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 09-05-2025 07-31-2025 10-Q
2 05-28-2025 04-30-2025 10-Q
3 03-13-2025 01-31-2025 10-K
4 12-09-2024 10-31-2024 10-Q
5 09-05-2024 07-31-2024 10-Q
6 05-31-2024 04-30-2024 10-Q
7 03-15-2024 01-31-2024 10-K
8 12-06-2023 10-31-2023 10-Q
9 09-07-2023 07-31-2023 10-Q
10 06-01-2023 04-30-2023 10-Q
11 03-23-2023 01-31-2023 10-K
12 12-09-2022 10-31-2022 10-Q
13 09-08-2022 07-31-2022 10-Q
14 06-03-2022 04-30-2022 10-Q
15 03-31-2022 01-31-2022 10-K
16 12-09-2021 10-31-2021 10-Q
17 09-02-2021 07-31-2021 10-Q
18 06-04-2021 04-30-2021 10-Q
19 03-31-2021 01-31-2021 10-K
20 12-09-2020 10-31-2020 10-Q
21 09-09-2020 07-31-2020 10-Q
22 06-09-2020 04-30-2020 10-Q
23 04-23-2020 01-31-2020 10-K
24 12-10-2019 10-31-2019 10-Q
25 09-10-2019 07-31-2019 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 keybanc-maintains-overweight-on-phreesia-lowers-price-target-to-32

Keybanc analyst Scott Schoenhaus maintains Phreesia (NYSE:PHR) with a Overweight and lowers the price target from $35 to $32.

 truist-securities-maintains-buy-on-phreesia-raises-price-target-to-36

Truist Securities analyst Jailendra Singh maintains Phreesia (NYSE:PHR) with a Buy and raises the price target from $35 to $36.

 jmp-securities-maintains-market-outperform-on-phreesia-raises-price-target-to-34

JMP Securities analyst Silvan Tuerkcan maintains Phreesia (NYSE:PHR) with a Market Outperform and raises the price target fr...

 canaccord-genuity-maintains-buy-on-phreesia-raises-price-target-to-38

Canaccord Genuity analyst Richard Close maintains Phreesia (NYSE:PHR) with a Buy and raises the price target from $34 to $38.

 analysts-weigh-integration-risks-as-phreesia-expands-with-new-deal

Phreesia gains analyst support with price target hikes, though integration risks and modest guidance raise tempered investor en...

 piper-sandler-maintains-overweight-on-phreesia-raises-price-target-to-34

Piper Sandler analyst Jessica Tassan maintains Phreesia (NYSE:PHR) with a Overweight and raises the price target from $33 to...

 needham-maintains-buy-on-phreesia-raises-price-target-to-35

Needham analyst Ryan MacDonald maintains Phreesia (NYSE:PHR) with a Buy and raises the price target from $29 to $35.

 phreesia-to-acquire-accessone-parent-holdings-for-aggregate-consideration-of-160m-in-cash

Phreesia, Inc. (NYSE:PHR) ("Phreesia"), a trusted leader in patient activation, today announced it has entered into a d...

 stephens--co-reiterates-overweight-on-phreesia-maintains-32-price-target

Stephens & Co. analyst Jeff Garro reiterates Phreesia (NYSE:PHR) with a Overweight and maintains $32 price target.

 phreesia-launches-voiceai-to-streamline-patient-calls-with-247-ai-powered-phone-support

New offering enhances Phreesia's existing platform, eliminating long hold times and ensuring every patient call is resolved...

 mizuho-initiates-coverage-on-phreesia-with-outperform-rating-announces-price-target-of-36

Mizuho analyst Steven Valiquette initiates coverage on Phreesia (NYSE:PHR) with a Outperform rating and announces Price Targ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION